The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 04, 2024
Filed:
Jun. 25, 2019
Applicant:
Innate Pharma, Marseilles, FR;
Inventors:
Cécile Bonnafous, Marseilles, FR;
Hélène Sicard, Marseilles, FR;
Renaud Buffet, Boulogne, FR;
Mathieu Blery, Marseilles, FR;
Assignee:
INNATE PHARMA, Marseilles, FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); C07K 16/30 (2006.01); G01N 33/574 (2006.01);
U.S. Cl.
CPC ...
C07K 16/28 (2013.01); C07K 16/2803 (2013.01); C07K 16/3061 (2013.01); G01N 33/57407 (2013.01); C07K 2317/73 (2013.01); C07K 2317/732 (2013.01); G01N 2333/70503 (2013.01);
Abstract
The present disclosure relates to methods for the treatment, prevention and diagnosis of peripheral T-cell lymphoma using compounds that specifically bind NKp46. Included in particular are compounds that bind NKp46 and deplete tumor cells that express NKp46 at their surface, and pharmaceutical compositions comprising the same. The disclosure also relates to the use of antibodies that specifically bind NKp46 in diagnostic and theranostic assays in the detection and treatment of peripheral T-cell lymphoma.